Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Enhanced DNA repair as a mechanism of resistance to cis-Diamminedichloroplatinum(II)

Journal Article · · Biochemistry; (United States)
DOI:https://doi.org/10.1021/bi00413a022· OSTI ID:6765431
Murine leukemia L1210 cells, either sensitive or resistant to the toxic action of the cancer chemotherapeutic agent cis-diamminedichloroplatinum(II), have been studied for potential differences in the formation and repair of drug-induced DNA damage. The sensitivity for these experiments was obtained by using the radiolabeled analogue (/sup 3/H)-cis-dichloro(ethylenediamine)platinum(II). The resistant cells demonstrated a 40% reduction in drug accumulation but a qualitatively similar profile of DNA-bound adducts. These adducts resembled those previously characterized in pure DNA and represented intrastrand cross-links at GG, AG, and GNG (N is any nucleotide) sequences in DNA. Repair of these cross-links occurred in a biphasic manner: rapid for the first 6 h and then much slower. The resistant cells removed up to 4 times as many adducts during the rapid phase of repair. The extent of this repair did not directly correlate with the degree of resistance in that cells with 100-fold resistance were only slightly more effective at repair than cells with 20-fold resistance. Therefore, although enhanced DNA repair is thought to contribute markedly to drug resistance, other mechanisms for tolerance of DNA damage may also occur in these cells.
Research Organization:
Univ. of Nebraska Medical Center, Omaha (USA)
OSTI ID:
6765431
Journal Information:
Biochemistry; (United States), Journal Name: Biochemistry; (United States) Vol. 27:13; ISSN BICHA
Country of Publication:
United States
Language:
English